The current state of tobacco cessation treatment

Nicotine addiction and dependence is a chronic relapsing disease driven by addiction to nicotine. Proactive treatment for all tobacco users, regardless of their readiness to quit, is recommended. First-line tobacco cessation medications include nicotine replacement therapy, bupropion, and varenicline. Comprehensive treatment with behavioral interventions and pharmacologic therapy increases success rates of smoking cessation. Although there are many popular alternative treatments, they should not replace or delay the use of known effective therapies. KEY POINTS An individualized treatment for tobacco cessation is necessary and should be based on severity of nicotine dependence, probability of developing withdrawal symptoms, comorbidities, local resources, and patient preferences. Comprehensive smoking cessation treatment provides counseling, assesses the patient's readiness to quit, offers treatment options, and arranges follow-up. Evidence is lacking to support the use of smart phone apps for smoking cessation as monotherapy. E-cigarettes are not used in tobacco cessation treatment as they can also cause nicotine addiction and other concerns.

Automated summary

Nicotine addiction is a chronic relapsing disease that requires proactive treatment with first-line medications such as nicotine replacement therapy, bupropion, and varenicline. Comprehensive smoking cessation treatment, based on individualized needs and preferences, is crucial for success. Avoiding the use of e-cigarettes and being cautious of alternative treatments are also key in tobacco cessation.